1. Price CP et al. Rapid and sensitive automated light scattering immunoassay for serum C-reac-
tive protein and the definition of a reference range in healthy blood donors. Clin Chem Lab Med.
1999; 37 (2): 109–13.
2. van Leeuwen MA & van Rijswijk MH. Acute phase proteins in the monitoring of inflammatory
disorders. Baillieres Clin Rheumatol. 1994; 8 (3): 531–52.
3. Olaison L et al. Fever C-reactive protein and other acute-phase reactants during treatment of
infective endocarditis. Arch Intern Med. 1997; 157 (8): 885–92.
4. Peltola H et al. Simplified treatment of acute staphylococcal osteomyelitis of childhood. Pediat-
rics.1997; 99 (6): 846–50.
5. Philip AGS & Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: Experience
with infants initially admitted to a well-baby nursery. Pediatrics. 2000; 106 (1): 1–5.
6. Pepys MB. The acute phase response and C-reactive protein. In: Warrell DA, Cox TM, Firth JD,
Benz EJ, (eds). Oxford Textbook of Medicine, 4th ed. Oxford University Press, 2003; 2: 150–6.
7. Chiesa C et al. C reactive protein and procalcitonin: Reference intervals for preterm and term
newborns during the early neonatal period. Clin Chim Acta. 2011; 412 (11-12): 1053–9.
8. Hofer N et al. Non-infectious conditions and gestational age influence C-reactive protein values
in newborns during the first 3 days of life. Clin Chem Lab Med. 2011; 49 (2): 297–302.
9. Wasunna A et al. C-reactive protein and bacterial infection in preterm infants. Eur J Pediatr.
1990; 149 (6): 424−7.
10. Pinto-Plata VM et al. C-reactive protein in patients with COPD, control smokers and non-smok-
ers. Thorax. 2006; 61 (1): 23–8.
11. Mannino DM et al. Obstructive and restrictive lung disease and markers of inflammation: data
from the Third National Health and Nutrition Examination. Am J Med. 2003; 114 (9): 758–62.
12. Dahl M et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med. 2007; 175 (3): 250−5.
13. Dessein PH et al. High sensitivity C-reactive protein as a disease activity marker in rheumatoid
arthritis. J Rheumatol. 2004; 31 (6): 1095−7.
14. Poole CD et al. The association between C-reactive protein and the likelihood of progression to
joint replacement in people with rheumatoid arthritis: a retrospective observational study. BMC
Musculoskelet Disord. 2008; 9: 146.
15. World Health Organization. Use of Anticoagulants in Diagnostic Laboratory Investigations &
Stability of blood, plasma and serum samples (WHO/DIL/LAB/99.1 Rev.2), 2002. Available:
http://whqlibdoc.who.int/hq/2002/WHO_DIL_LAB_99.1_Rev.2.pdf. Accessed 21.8.2014.
16. Thomas L. C-reaktives Protein (CRP) In: Labor und Diagnose, 4th ed. Marburg: Die Medizinis-
che Verlagsgesellschaft, 1992, 780−90.
17. Shine et al. Solid phase immunoassays for human C-reactive protein. Clin Chim Acta. 1981;
117: 13-23.
18. Schlebusch H et al. High Sensitive CRP and Creatinine: Reference intervals from Infancy to
Childhood. J Lab Med 2002; 26 (5/6): 341-6.
Sümbolite seletus ● Simbolių paaiškinimas
M
6 M
QuikRead go
on Orion Diagnostica Oy poolt registreeritud kaubamärk.
®
QuikRead go
yra Orion Diagnostica Oy registruotas prekinis ženklas.
®
Orion Diagnostica Oy
Koivu-Mankkaan tie 6 B
P.O. Box 83, FI-02101 Espoo, Finland
www.oriondiagnostica.com
www.quikread.com
Viited ● Nuorodos
Eesti
Meditsiiniline in vitro
diagnostikavahend
Kataloogi number
Partii kood
Kasutada
Säilivusaeg pärast avamist
3 kuud
Säilivusaeg pärast avamist
6 kuud
Temperatuuri piirang
Loe juhendit enne kasutamist
Tootja
Piisav
Sisu
Reagendikorgid
Puhver
Proovikoguja
Etüleendiamiintetraäädikhape
Päritolu: lammas
Sisaldab naatriumasiidi
Sisaldab
metüülkloroisotiasolinooni ja
metüülisotiasolinooni segu
Lietuviškai
In vitro diagnostikos
medicinos prietaisas
Kataloginis numeris
Partijos kodas
Nautido iki
Naudojimo trukmė atidarius
3 mėnesiai
Naudojimo trukmė atidarius
6 mėnesiai
Temperatūros apribojimas
Žiūrėkite naudojimo
taisykles
Gamintojas
Pakanka
Turinys
Reagento dangteliai
Buferis
Mėginio surinkėjas
Etilendiamintetraacto rūgštis
Kilmė: avis
Sudėtyje yra natrio azido
Sudėtyje yra metil-
chlorizotiazolinono ir
metilizotiazolinono mišinys